Matches in SemOpenAlex for { <https://semopenalex.org/work/W1907408825> ?p ?o ?g. }
- W1907408825 endingPage "3419" @default.
- W1907408825 startingPage "3409" @default.
- W1907408825 abstract "// Catherine E. Waters 1, 2 , Joshua C. Saldivar 3 , Zaynab A. Amin 2 , Morgan S. Schrock 1, 2 , Kay Huebner 2 1 Biomedical Sciences Graduate Program, Ohio State University Wexner Medical Center, Columbus, Ohio 2 Department of Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, Ohio State University Wexner Medical Center, Columbus, 43210, Ohio 3 Department of Chemical and Systems Biology, Stanford University School of Medicine, Standford, 94305, California Correspondence to: Kay Huebner, e-mail: kay.huebner@osumc.edu Keywords: FHIT, replication stress, DNA double strand breaks, APOBEC deaminase, mutations Received: August 14, 2014 Accepted: October 23, 2014 Published: October 31, 2014 ABSTRACT APOBEC cytidine deaminase activity is a major source of hypermutation in cancer. But previous studies have shown that the TC context signature of these enzymes is not observed in sizable fractions of cancers with overexpression of APOBEC, suggesting that cooperating factors that contribute to this mutagenesis should be identified. The fragile histidine triad protein (Fhit) is a tumor suppressor and DNA caretaker that is deleted or silenced in >50% of cancers. Loss of Fhit protein activity causes replication stress through reduced Thymidine Kinase 1 expression, increased DNA breaks, and global genome instability in normal and cancer cells. Using data from The Cancer Genome Atlas (TCGA), we show that FHIT -low/ APOBEC3B -high expressing lung adenocarcinomas display significantly increased numbers of APOBEC signature mutations. Tumor samples in this cohort with normal FHIT expression do not exhibit APOBEC hypermutation, despite having high APOBEC3B expression. In vitro , silencing Fhit expression elevates APOBEC3B-directed C > T mutations in the TP53 gene. Furthermore, inhibition of Fhit loss-induced DNA damage via thymidine supplementation decreases the TP53 mutation burden in FHIT -low/ APOBEC3B -high cells. We conclude that APOBEC3B overexpression and Fhit-loss induced DNA damage are independent events that, when occurring together, result in a significantly increased frequency of APOBEC-induced mutations that drive cancer progression." @default.
- W1907408825 created "2016-06-24" @default.
- W1907408825 creator A5011519726 @default.
- W1907408825 creator A5012917331 @default.
- W1907408825 creator A5037630850 @default.
- W1907408825 creator A5065728087 @default.
- W1907408825 creator A5086420049 @default.
- W1907408825 date "2014-10-31" @default.
- W1907408825 modified "2023-10-03" @default.
- W1907408825 title "<i>FHIT</i> loss-induced DNA damage creates optimal APOBEC substrates: Insights into APOBEC-mediated mutagenesis" @default.
- W1907408825 cites W1533555842 @default.
- W1907408825 cites W1595351866 @default.
- W1907408825 cites W1899791338 @default.
- W1907408825 cites W1967630574 @default.
- W1907408825 cites W1976837595 @default.
- W1907408825 cites W1978469053 @default.
- W1907408825 cites W1984236815 @default.
- W1907408825 cites W1992606846 @default.
- W1907408825 cites W1993004107 @default.
- W1907408825 cites W1996486420 @default.
- W1907408825 cites W1997746246 @default.
- W1907408825 cites W2003665515 @default.
- W1907408825 cites W2019276374 @default.
- W1907408825 cites W2021366863 @default.
- W1907408825 cites W2031739677 @default.
- W1907408825 cites W2048712200 @default.
- W1907408825 cites W2062284662 @default.
- W1907408825 cites W2070150030 @default.
- W1907408825 cites W2070554004 @default.
- W1907408825 cites W2082348607 @default.
- W1907408825 cites W2091939828 @default.
- W1907408825 cites W2100091975 @default.
- W1907408825 cites W2101836667 @default.
- W1907408825 cites W2104153021 @default.
- W1907408825 cites W2106174263 @default.
- W1907408825 cites W2111249832 @default.
- W1907408825 cites W2117692326 @default.
- W1907408825 cites W2129136620 @default.
- W1907408825 cites W2130741439 @default.
- W1907408825 cites W2147098985 @default.
- W1907408825 cites W2152061559 @default.
- W1907408825 cites W2155056168 @default.
- W1907408825 cites W2158266834 @default.
- W1907408825 cites W2159082261 @default.
- W1907408825 cites W2166673658 @default.
- W1907408825 cites W2318256082 @default.
- W1907408825 cites W4239200565 @default.
- W1907408825 doi "https://doi.org/10.18632/oncotarget.2636" @default.
- W1907408825 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4413662" @default.
- W1907408825 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25401976" @default.
- W1907408825 hasPublicationYear "2014" @default.
- W1907408825 type Work @default.
- W1907408825 sameAs 1907408825 @default.
- W1907408825 citedByCount "28" @default.
- W1907408825 countsByYear W19074088252015 @default.
- W1907408825 countsByYear W19074088252016 @default.
- W1907408825 countsByYear W19074088252017 @default.
- W1907408825 countsByYear W19074088252018 @default.
- W1907408825 countsByYear W19074088252020 @default.
- W1907408825 countsByYear W19074088252022 @default.
- W1907408825 countsByYear W19074088252023 @default.
- W1907408825 crossrefType "journal-article" @default.
- W1907408825 hasAuthorship W1907408825A5011519726 @default.
- W1907408825 hasAuthorship W1907408825A5012917331 @default.
- W1907408825 hasAuthorship W1907408825A5037630850 @default.
- W1907408825 hasAuthorship W1907408825A5065728087 @default.
- W1907408825 hasAuthorship W1907408825A5086420049 @default.
- W1907408825 hasBestOaLocation W19074088251 @default.
- W1907408825 hasConcept C104317684 @default.
- W1907408825 hasConcept C121608353 @default.
- W1907408825 hasConcept C128526571 @default.
- W1907408825 hasConcept C141231307 @default.
- W1907408825 hasConcept C159654299 @default.
- W1907408825 hasConcept C16318435 @default.
- W1907408825 hasConcept C2776162770 @default.
- W1907408825 hasConcept C2778264664 @default.
- W1907408825 hasConcept C2778453870 @default.
- W1907408825 hasConcept C2780646079 @default.
- W1907408825 hasConcept C501734568 @default.
- W1907408825 hasConcept C502942594 @default.
- W1907408825 hasConcept C54355233 @default.
- W1907408825 hasConcept C555283112 @default.
- W1907408825 hasConcept C86803240 @default.
- W1907408825 hasConceptScore W1907408825C104317684 @default.
- W1907408825 hasConceptScore W1907408825C121608353 @default.
- W1907408825 hasConceptScore W1907408825C128526571 @default.
- W1907408825 hasConceptScore W1907408825C141231307 @default.
- W1907408825 hasConceptScore W1907408825C159654299 @default.
- W1907408825 hasConceptScore W1907408825C16318435 @default.
- W1907408825 hasConceptScore W1907408825C2776162770 @default.
- W1907408825 hasConceptScore W1907408825C2778264664 @default.
- W1907408825 hasConceptScore W1907408825C2778453870 @default.
- W1907408825 hasConceptScore W1907408825C2780646079 @default.
- W1907408825 hasConceptScore W1907408825C501734568 @default.
- W1907408825 hasConceptScore W1907408825C502942594 @default.
- W1907408825 hasConceptScore W1907408825C54355233 @default.
- W1907408825 hasConceptScore W1907408825C555283112 @default.
- W1907408825 hasConceptScore W1907408825C86803240 @default.